Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neisseria Meningitidis”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Not applicableStudy completedNCT02844088
What this trial is testing

Evaluation of Vaccinal and Natural Immunity Against Meningococcus C

Who this might be right for
Prevention of Meningococcus C Infections
University Hospital, Clermont-Ferrand 184
Early research (Phase 1)Looking for participantsNCT07395739
What this trial is testing

A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104

Who this might be right for
Neisseria Meningitidis Serogroup B
Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) 30
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Large-scale testing (Phase 3)Study completedNCT00263653
What this trial is testing

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 297
Large-scale testing (Phase 3)Study completedNCT01900899
What this trial is testing

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Who this might be right for
Infections, Meningococcal
Pfizer 184
Large-scale testing (Phase 3)Study completedNCT01340898
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Who this might be right for
Meningococcal Infection
GlaxoSmithKline 753
Not applicableStudy completedNCT02249598
What this trial is testing

Competitive Carriage of Neisseria Spp(Lactamica 2)

Who this might be right for
Neisseria Lactamica
Sheffield Teaching Hospitals NHS Foundation Trust 300
Testing effectiveness (Phase 2)Study completedNCT00871338
What this trial is testing

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 284
Testing effectiveness (Phase 2)Study completedNCT02853617
What this trial is testing

AV0328 Administered to Healthy Adult Volunteers

Who this might be right for
PNAG-expressing Pathogenic Microbes Vaccine
Alopexx Vaccine, LLC 16
Testing effectiveness (Phase 2)Study completedNCT03295318
What this trial is testing

Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds

Who this might be right for
Meningitis, Meningococcal
Serum Institute of India Pvt. Ltd. 375
Post-approval studies (Phase 4)Study completedNCT00454987
What this trial is testing

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria MeningitidisNeisseria Meningitidis-Haemophilus Influenzae Type b Vaccine
GlaxoSmithKline 288
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Not applicableEnded earlyNCT00465582
What this trial is testing

B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors

Who this might be right for
Meningococcal Infections
University Hospital, Rouen 3,296
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Testing effectiveness (Phase 2)Study completedNCT00721396
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,885
Post-approval studies (Phase 4)Study completedNCT00119080
What this trial is testing

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
Centers for Disease Control and Prevention 4,000
Large-scale testing (Phase 3)Study completedNCT04707391
What this trial is testing

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,250
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT01621945
What this trial is testing

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)

Who this might be right for
Neisseria Meningitidis
University Hospital, Rouen 120
Large-scale testing (Phase 3)Study completedNCT01839188
What this trial is testing

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 385
Next Page